Debt-to-equity of Autolus Therapeutics plc from 31 Mar 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Autolus Therapeutics plc quarterly Debt-to-equity in % history and change rate from 31 Mar 2020 to 30 Sep 2025.
  • Autolus Therapeutics plc Debt-to-equity for the quarter ending 30 Sep 2025 was 106%, a 44% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Autolus Therapeutics plc Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 106% +32% +44% 30 Sep 2025
Q2 2025 90% +8.8% +11% 30 Jun 2025
Q1 2025 78% -15% -16% 31 Mar 2025
Q4 2024 67% -48% -42% 31 Dec 2024
Q3 2024 74% -11% -13% 30 Sep 2024
Q2 2024 81% +6.8% +9.2% 30 Jun 2024
Q1 2024 93% +31% +50% 31 Mar 2024
Q4 2023 115% +63% +123% 31 Dec 2023
Q3 2023 85% +45% +111% 30 Sep 2023
Q2 2023 74% 30 Jun 2023
Q1 2023 62% 31 Mar 2023
Q4 2022 51% 31 Dec 2022
Q3 2022 40% 30 Sep 2022
Q1 2021 26% +9.2% +53% 31 Mar 2021
Q4 2020 27% 31 Dec 2020
Q3 2020 22% 30 Sep 2020
Q2 2020 18% 30 Jun 2020
Q1 2020 17% 31 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.